Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 2/20 | 0.53 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.53 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.45 |
| ▸ | ELANE | P08246 | 1/20 | 0.42 |
| ▸ | CTSG | P08311 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CRHBP | P24387 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | IAPP | P10997 | 1/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.40 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.40 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL108067 | 0.90 | GABRA1 (0.64) | GABRA1GABRB2AKR1B1POLBMAPK1 | |
| Formaldehyde SCHEMBL14742618 | 0.88 | GABRA1 (0.57) | GABRA1GABRB2AKR1B1POLBMAPK1 | |
| SCHEMBL27513033 | 0.88 | GABRA1 (0.61) | GABRA1GABRB2AKR1B1POLBMAPK1 | |
| Methoxymethane SCHEMBL29084367 | 0.84 | GABRA1 (0.57) | GABRA1GABRB2AKR1B1POLBMAPK1 | |
| Bicarbonate SCHEMBL27740095 | 0.84 | HSPA5 (0.55) | GABRA1GABRB2AKR1B1POLBMAPK1 | |
| Bicarbonate SCHEMBL27568192 | 0.81 | GABRA1 (0.58) | GABRA1GABRB2AKR1B1RAB9ATSHR | |
| SCHEMBL15942178 | 0.81 | AKR1B1 (0.48) | GABRA1GABRB2AKR1B1POLBMAPK1 | |
| SCHEMBL5311363 | 0.81 | POLB (0.57) | AKR1B1POLBMAPK1HSPA5ELANE | |
| Acetic Acid SCHEMBL27895243 | 0.79 | AKR1B1 (0.61) | GABRA1GABRB2AKR1B1HSPA5CYP2D6 | |
| SCHEMBL10457141 | 0.79 | AKR1B1 (0.52) | AKR1B1POLBMAPK1HSPA5MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4299705-B1 | A PROCESS FOR MAKING A COMPOSITION COMPRISING ALKYL POLYGLYCOSIDE AND PERFUME | PROCTER & GAMBLE (US) | 2025-12-17 | — | — | EP | disclosed |
| EP-4299705-A1 | A PROCESS FOR MAKING A COMPOSITION COMPRISING ALKYL POLYGLYCOSIDE AND PERFUME | The Procter & Gamble Company (US) | 2024-01-03 | — | — | EP | disclosed |
| US-20230414474-A1 | PROCESS FOR MAKING A COMPOSITION COMPRISING ALKYL POLYGLYCOSIDE AND PERFUME | THE PROCTER & GAMBLE COMPANY | 2023-12-28 | — | — | US | disclosed |
| EP-0075976-B1 | ALKALINE AQUEOUS LIQUID DETERGENT COMPOSITIONS CONTAINING NORMALLY UNSTABLE ESTER PERFUMES | THE PROCTER & GAMBLE COMPANY (US) | 1985-06-19 | — | — | EP | disclosed |
| US-4440663-A | Alkaline aqueous liquid detergent compositions containing normally unstable ester perfumes | THE PROCTER & GAMBLE COMPANY (US) | 1984-04-03 | — | — | US | disclosed |
| EP-0075976-A1 | Alkaline aqueous liquid detergent compositions containing normally unstable ester perfumes | THE PROCTER & GAMBLE COMPANY (US) | 1983-04-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230414474-A1 | PROCESS FOR MAKING A COMPOSITION COMPRISING ALKYL POLYGLYCOSIDE AND PERFUME | FUT8, PLG, PIGS | GABRA1 2480/4885GABRB2 2246/4885AKR1B1 610/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.